Marinomed Biotech AG

Marinomed Biotech AGverified

MARI.VI

Price:

$19.7

Market Cap:

$35.03M

Marinomed Biotech AG, a biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally. Its products pipeline includes Budesolv for the treatment of allergic rhinitis and autoimmune gastritis; Tacrosolv, which is in Phase II clinical trial for anterior inflammatory eye diseases; Carravin for the treatment of nasal congestion; and Inhaleen that is in Phase I clinical trial for viral pneumonia, as well as Carragelose, which consists of nasal and throat sprays, and lozenges for treating viral respiratory infections. The company was formerly known as Marinomed Biotechnologie GmbH and changed its name t...[Read more]

Industry

Biotechnology

IPO Date

2019-02-01

Stock Exchange

VIE

Ticker

MARI.VI

The PE Ratio as of December 2025 (TTM) for Marinomed Biotech AG (MARI.VI) is 3.61

According to Marinomed Biotech AG’s latest financial reports and current stock price. The company's current PE Ratio is 3.61. This represents a change of -421.27% compared to the average of -1.12 of the last 4 quarters.

Marinomed Biotech AG (MARI.VI) Historical PE Ratio (quarterly & annually)

How has MARI.VI PE Ratio performed in the past?

The mean historical PE Ratio of Marinomed Biotech AG over the last ten years is -29.48. The current 3.61 PE Ratio has changed -1324.54% with respect to the historical average. Over the past ten years (40 quarters), MARI.VI's PE Ratio was at its highest in in the December 2021 quarter at 79.11. The PE Ratio was at its lowest in in the December 2017 quarter at -157.23.

Quarterly (TTM)
Annual

Average

-29.48

Median

-20.85

Minimum

-83.44

Maximum

-1.73

Marinomed Biotech AG (MARI.VI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Marinomed Biotech AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 101.53%

Maximum Annual PE Ratio = -1.73

Minimum Annual Increase = -80.34%

Minimum Annual PE Ratio = -83.44

Quarterly (TTM)
Annual
YearPE RatioChange
2024-1.73-73.48%
2023-6.52-50.63%
2022-13.21-40.06%
2021-22.05-24.32%
2020-29.1348.24%
2019-19.65101.53%
2018-9.75-80.34%
2017-49.60-16.96%
2016-59.72-28.42%

Marinomed Biotech AG (MARI.VI) Average PE Ratio

How has MARI.VI PE Ratio performed in the past?

The current PE Ratio of Marinomed Biotech AG (MARI.VI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-7.16

5-year avg

-14.53

10-year avg

-29.48

Marinomed Biotech AG (MARI.VI) PE Ratio vs. Peers

How is MARI.VI’s PE Ratio compared to its peers?

Marinomed Biotech AG’s PE Ratio is

CompanyPE RatioMarket cap

Build a custom stock screener for Marinomed Biotech AG (MARI.VI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marinomed Biotech AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Marinomed Biotech AG (MARI.VI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Marinomed Biotech AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Marinomed Biotech AG's PE Ratio?

How is the PE Ratio calculated for Marinomed Biotech AG (MARI.VI)?

What is the highest PE Ratio for Marinomed Biotech AG (MARI.VI)?

What is the 3-year average PE Ratio for Marinomed Biotech AG (MARI.VI)?

What is the 5-year average PE Ratio for Marinomed Biotech AG (MARI.VI)?

How does the current PE Ratio for Marinomed Biotech AG (MARI.VI) compare to its historical average?